Samrat Pharmachem reports standalone net profit of Rs 1.40 crore in the March 2024 quarter

Sales rise 19.51% to Rs 82.68 crore

Net profit of Samrat Pharmachem reported to Rs 1.40 crore in the quarter ended March 2024 as against net loss of Rs 0.74 crore during the previous quarter ended March 2023. Sales rose 19.51% to Rs 82.68 crore in the quarter ended March 2024 as against Rs 69.18 crore during the previous quarter ended March 2023.

For the full year,net profit declined 87.01% to Rs 2.16 crore in the year ended March 2024 as against Rs 16.63 crore during the previous year ended March 2023. Sales declined 9.36% to Rs 281.58 crore in the year ended March 2024 as against Rs 310.65 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales82.6869.18 20 281.58310.65 -9 OPM %1.66-0.71 -0.887.70 - PBDT1.56-0.63 LP 3.1723.17 -86 PBT1.40-0.79 LP 2.5222.53 -89 NP1.40-0.74 LP 2.1616.63 -87

Powered by Capital Market - Live News